XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study

✍ Scribed by Rosati, Gerardo; Avallone, Antonio; Aprile, Giuseppe; Butera, Alfredo; Reggiardo, Giorgio; Bilancia, Domenico

• Book ID: 118070832
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 269 KB
• Volume: 71
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-012-2004-x